As of Feb 20, 2025, LifeStance Health Group, Inc.'s fair value using the Peter Lynch formula is $12.1 per share. The current price of $7.9 suggests LifeStance Health Group, Inc. may be undervalued by this metric.
As of Feb 20, 2025, LifeStance Health Group, Inc.'s P/E ratio is (31.0x). This is calculated by dividing the current share price of $7.9 by the Earnings per Share (EPS) for the trailing twelve months, which is ($0.3). The P/E ratio indicates how much investors are willing to pay for each dollar of earnings.
LifeStance Health Group, Inc. earnings per share (EPS) for the twelve months ending Feb 20, 2025, was ($0.3), a (47.4%) growth year-over-year.